Cargando…

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction

BACKGROUND: Cardiac remodeling is a process mediated, in part, by 18-hydroxyeicosapentaenoic acid (HEPE), a metabolite of the omega-3 polyunsaturated fatty acid, eicosapentaenoic acid (EPA). We hypothesized that trans-myocardial levels of 18-HEPE could inform the pathophysiologic processes involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keeley, Ellen C., Handberg, Eileen M., Noel Bairey Merz, C., Pepine, Carl J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297500/ https://www.ncbi.nlm.nih.gov/pubmed/37377675 http://dx.doi.org/10.1016/j.ahjo.2022.100213

Ejemplares similares

Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia
por: Mohandas, Rajesh, et al.
Publicado: (2015)

Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker
por: Pacheco, Christine, et al.
Publicado: (2021)

Circulating Biomarkers in Coronary Microvascular Dysfunction
por: Chakrala, Teja, et al.
Publicado: (2023)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
por: Jones, Erika, et al.
Publicado: (2020)

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) project
por: Chen, Melanie T., et al.
Publicado: (2023)

Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know
por: Marano, Paul, et al.
Publicado: (2023)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study
por: Jalnapurkar, Sawan, et al.
Publicado: (2021)

Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)
por: Taha, Yasmeen K., et al.
Publicado: (2023)

Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project
por: Siak, Jessica, et al.
Publicado: (2021)

Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
por: Anderson, R. David, et al.
Publicado: (2019)

Native myocardial T1 is elevated in subjects with coronary microvascular dysfunction and no obstructive CAD
por: Shaw, Jaime L, et al.
Publicado: (2015)

Sex differences in contributors to coronary microvascular dysfunction
por: Kwan, Alan C., et al.
Publicado: (2023)

Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial
por: Birkeland, Kade, et al.
Publicado: (2017)

Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women’s Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects
por: Virzi, Nicole E., et al.
Publicado: (2022)

Number and Function of Bone-Marrow Derived Angiogenic Cells and Coronary Flow Reserve in Women without Obstructive Coronary Artery Disease: A Substudy of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Mohandas, Rajesh, et al.
Publicado: (2013)

Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve
por: AlBadri, Ahmed, et al.
Publicado: (2017)

THE IMPACT OF THE COVID-19 PANDEMIC ON A MULTI-CENTER CLINICAL - ADAPTING IN REAL-TIME TO MAINTAIN TRIAL INTEGRITY
por: Dasa, Osama, et al.
Publicado: (2021)

Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)
por: Sedlak, Tara, et al.
Publicado: (2020)

Cardiovascular and pregnancy outcomes in women with coronary microvascular dysfunction: a case series
por: Pacheco, Christine, et al.
Publicado: (2019)

Comparison of fully quantitative and semi-quantitative measure of women's myocardial perfusion reserve for detection of microvascular coronary dysfunction
por: Chen, David, et al.
Publicado: (2013)

Coronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain
por: Manchanda, Ashley S., et al.
Publicado: (2022)

Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy
por: Quesada, Odayme, et al.
Publicado: (2020)

Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1‐Year Follow‐Up: Results From WISE‐CVD
por: Quesada, Odayme, et al.
Publicado: (2020)

Microvascular Angina: Diagnosis and Management
por: Aldiwani, Haider, et al.
Publicado: (2021)

Myocardial Infarction and Persistent Angina With No Obstructive Coronary Artery Disease
por: Malas, Waddah, et al.
Publicado: (2020)

TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
por: Petersen, John W., et al.
Publicado: (2014)

Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women’s Ischemia Syndrome Evaluation
por: Emami, Ashley S., et al.
Publicado: (2021)

Interscan reproducibility of cardiovascular magnetic resonance myocardial perfusion reserve index in women with suspected coronary microvascular dysfunction and no obstructive coronary artery disease
por: AlBadri, Ahmed, et al.
Publicado: (2016)

Brachial Artery Constriction during Brachial Artery Reactivity Testing Predicts Major Adverse Clinical Outcomes in Women with Suspected Myocardial Ischemia: Results from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
por: Sedlak, Tara L., et al.
Publicado: (2013)

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
por: Joung, Sandy, et al.
Publicado: (2019)

Migraine Headache: An Under‐Appreciated Risk Factor for Cardiovascular Disease in Women
por: Elgendy, Islam Y., et al.
Publicado: (2019)

Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women?
por: Quesada, Odayme, et al.
Publicado: (2022)

Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome
por: Quesada, Odayme, et al.
Publicado: (2023)

Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When
por: Ford, Thomas J., et al.
Publicado: (2020)

Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease
por: Raad, Mohamad, et al.
Publicado: (2020)

Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE)
por: Jones, Erika, et al.
Publicado: (2020)

Optimal systolic blood pressure and reduced long-term mortality in older hypertensive women with prior coronary events – An analysis from INVEST☆()
por: Sava, Ruxandra I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0j5k60a45ho97f1i4731ub9ne5